1. Home
  2. SRI vs DTIL Comparison

SRI vs DTIL Comparison

Compare SRI & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$7.64

Market Cap

161.7M

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$6.14

Market Cap

185.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
DTIL
Founded
1965
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
185.3M
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
SRI
DTIL
Price
$7.64
$6.14
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$16.00
$45.00
AVG Volume (30 Days)
135.7K
350.0K
Earning Date
05-01-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$824,444,000.00
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.46
N/A
52 Week Low
$4.60
$3.53
52 Week High
$9.71
$8.82

Technical Indicators

Market Signals
Indicator
SRI
DTIL
Relative Strength Index (RSI) 57.95 39.09
Support Level $7.26 $4.98
Resistance Level $7.94 $8.12
Average True Range (ATR) 0.39 0.67
MACD -0.03 -0.09
Stochastic Oscillator 67.83 6.76

Price Performance

Historical Comparison
SRI
DTIL

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: